30 August 2022>: Original Paper
Clinical Validation of a Novel Scoring System Based on Donor and Recipient Risk Factors for Predicting Outcomes in Liver Transplantation
Lucas Souto Nacif ABCDEF* , Daniel Reis Waisberg CDE , Leonardo Yuri Zanini BCDEF , Rafael Soares Pinheiro ACD , Vinicius Rocha-Santos ACD , Rubens Arantes Macedo BD , Liliana Ducatti BD , Luciana Haddad BD , Rodrigo Bronze de Martino ACDE , Flávio Galvão AD , Wellington Andraus ACD , Luiz Carneiro-D’Albuquerque ADDOI: 10.12659/AOT.936271
Ann Transplant 2022; 27:e936271
Table 2 Log-rank test of all scores variables (30% bank randomly selected).
n | Events | Mean | SD | IC (95%) | p-value | ||
---|---|---|---|---|---|---|---|
Donor age | 249 | 66 | 2753 | 113 | (2739–2767) | 0.435 | |
60–65 | 16 | 5 | 2610 | 454 | (2388–2832) | ||
65–70 | 12 | 4 | 2477 | 532 | (2176–2778) | ||
≥70 | 3 | 2 | 1285 | 1041 | (107–2463) | ||
Steatosis ≥30% | No | 185 | 45 | 3065 | 136 | (3045–3085) | 0.141 |
Yes | 61 | 20 | 2619 | 269 | (2551–2687) | ||
Nora ≥1 mcg/kg/min | No | 255 | 70 | 2980 | 124 | (2965–2995) | 0.545 |
Yes | 10 | 2 | 3366 | 531 | (3037–3695) | ||
Cardiopulmonary arrest >2 minutes | No | 234 | 72 | 2941 | 141 | (2923–2959) | 0.002 |
Yes | 41 | 3 | 4055 | 186 | (3998–4112) | ||
pH ≥7.20 | No | 236 | 65 | 3233 | 145 | (3215–3251) | 0.966 |
Yes | 37 | 10 | 3325 | 346 | (3214–3436) | ||
≥7 days ICU | No | 195 | 44 | 3498 | 147 | (3477–3519) | 0.006 |
Yes | 81 | 32 | 2670 | 262 | (2613–2727) | ||
Recipient’s age | 198 | 55 | 2865 | 135 | (2846–2884) | 0.878 | |
60–65 | 45 | 11 | 3048 | 262 | (2971–3125) | ||
65–70 | 30 | 9 | 2530 | 417 | (2381–2679) | ||
≥70 | 7 | 2 | 2780 | 754 | (2221–3339) | ||
Retransplant | No | 259 | 77 | 2500 | 102 | (2488–2512) | 0.196 |
Yes | 21 | 0 | 3570 | 0 | (3570–3570) | ||
Fulminant | No | 257 | 65 | 2942 | 116 | (2928–2956) | 0.004 |
Yes | 23 | 12 | 1842 | 431 | (1666–2018) | ||
Portal trunk thrombosis | No | 226 | 60 | 2717 | 118 | (2702–2732) | 0.990 |
Yes | 35 | 9 | 2689 | 316 | (2584–2794) | ||
Large surgery/biliary tree surgery | No | 220 | 57 | 3105 | 136 | (3087–3123) | 0.695 |
Yes | 45 | 13 | 3021 | 301 | (2933–3109) | ||
Cardiac risk >moderate | No | 95 | 15 | 1947 | 92.5 | (1928–1966) | 0.216 |
Yes | 6 | 2 | 1099 | 634.4 | (591–1607) | ||
MELD | 165 | 27 | 3135 | 120 | (3117–3153) | ||
24–29 | 35 | 12 | 2480 | 313 | (2378–2582) | ||
29–35 | 36 | 12 | 2534 | 299 | (2436–2632) | ||
>35 | 42 | 24 | 1535 | 296 | (1445–1625) | ||
Cause of donor death | CVAh | 132 | 34 | 2644 | 144 | (2619–2669) | 0.102 |
CVAi | 17 | 7 | 2037 | 442 | (1827–2247) | ||
TCE | 99 | 29 | 2489 | 176 | (2454–2524) | ||
Anoxia | 20 | 2 | 3232 | 264 | (3116–3348) | ||
Brain tumor | 4 | 3 | 927 | 779 | (164–1690) | ||
Others | 7 | 1 | 3108 | 479 | (2753–3463) | ||
Creatinine before transplant >1.5 mg/dL | No | 216 | 44 | 3177 | 119 | (3161–3193) | |
Yes | 63 | 33 | 1812 | 262 | (1747–1877) | ||
SD – standard deviation; IC – confidence index. ICU – Intensive Care Unit; MELD – model of end stage liver disease. |